Zobrazeno 1 - 10
of 381
pro vyhledávání: '"S, Tognella"'
Autor:
R.W. Dal Negro, C. Micheletto, S. Tognella, C. Turati, R. Bisato, M. Guerriero, M. Sandri, P. Turco
Publikováno v:
Monaldi Archives for Chest Disease, Vol 67, Iss 2 (2016)
Background and Aim. Subjects with airway obstruction are strongly recommended to monitor their lung function, which is particularly variable in asthma. Unlike PEFR, other personal measurements (such as FEV1) are still difficult to perform. PIKO-1 is
Externí odkaz:
https://doaj.org/article/52035fdab7804d008fd161959063d362
Publikováno v:
Monaldi Archives for Chest Disease, Vol 73, Iss 1 (2016)
Aim. Aim of the study was to investigate whether or not oral supplementation of essential amino acids (EAAs) may improve body composition, muscle metabolism, physical activity, cognitive function, and health status in a population of subjects with se
Externí odkaz:
https://doaj.org/article/3883c0a859814f589ef3149d8373cc6a
Publikováno v:
Monaldi Archives for Chest Disease, Vol 75, Iss 3 (2015)
Bronchiectasis is a chronic respiratory disease which recognises different etiologies, and characterised by persistent cough, bronchial hypersecretion, airway colonisation with Gram-negative pathogens; frequent infectious exacerbations; progressive l
Externí odkaz:
https://doaj.org/article/1a90a0779211435ab438bc5baf15f91d
Publikováno v:
Monaldi Archives for Chest Disease, Vol 77, Iss 2 (2015)
Background. Pulmonary Rehabilitation (“Rehabilitation”) can improve both lung function and quality of life in patients suffering from chronic obstructive pulmonary disease (COPD) even if only a very small proportion of patients have access to Reh
Externí odkaz:
https://doaj.org/article/50a03c48c46b4643a27b2d7060a223c6
Autor:
M, Caminati, G, Senna, G, Stefanizzi, R, Bellamoli, S, Longhi, F, Chieco-Bianchi, G, Guarnieri, S, Tognella, M, Olivieri, C, Micheletto, G, Festi, E, Bertocco, M, Mazza, A, Rossi, A, Vianello, M, Schiappoli
Publikováno v:
BMC Pulmonary Medicine
Background In patients with asthma, particularly severe asthma, poor adherence to inhaled drugs negatively affects the achievement of disease control. A better adherence rate is expected in the case of injected drugs, such as omalizumab, as they are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75507fa606cea5bda9df6403ea81fa62
http://hdl.handle.net/11577/3292941
http://hdl.handle.net/11577/3292941
Publikováno v:
European annals of allergy and clinical immunology. 43(2)
Omalizumab (OM), an innovative biological treatment for difficult asthma with perennial sensitisations, is an humanized monoclonal anti-IgE antibody that binds free circulating IgE; inhibits mast cell and basophil activation by combining free IgE, le
Publikováno v:
European annals of allergy and clinical immunology. 43(1)
The definition of reference normal values for urinary LTE4 still represents an open question.to assess the influence of gender and age on urinary LTE4 levels in normal individuals.after their informed consent, urinary LTE4 was measured in 124 well ma
Publikováno v:
European annals of allergy and clinical immunology. 42(3)
Several comorbid conditions may contribute to worsening asthma symptoms, including nasal polyps (NPs). Cysteinyl leukotrienes (Cys-LTs) play a crucial role in asthma pathophysiology, and specific receptors for CysLTs are reported as upregulated in na
Publikováno v:
European annals of allergy and clinical immunology. 39(5)
Aspirin induced asthma (AIA) is a syndrome characterised by intolerance to acetylsalycilic acid (ASA), nasal polyps and bronchial asthma, being the metabolic shift of arachidonic acid toward the lipoxygenase pathway and hyper-production of cysteinyl-
Publikováno v:
European annals of allergy and clinical immunology. 38(5)
Bronchial asthma is defined as "a chronic inflammatory disease of the airways involving many cells" and inhaled corticosteroids have therefore become the fundamental drugs for the long-term management of the disease. In moderate and severe persistent